![Prediction of blood-based biomarkers and subsequent design of bisulfite PCR-LDR-qPCR assay for breast cancer detection | BMC Cancer | Full Text Prediction of blood-based biomarkers and subsequent design of bisulfite PCR-LDR-qPCR assay for breast cancer detection | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-6574-4/MediaObjects/12885_2020_6574_Fig5_HTML.png)
Prediction of blood-based biomarkers and subsequent design of bisulfite PCR-LDR-qPCR assay for breast cancer detection | BMC Cancer | Full Text
![Cancers | Free Full-Text | In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer Cancers | Free Full-Text | In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer](https://pub.mdpi-res.com/cancers/cancers-10-00517/article_deploy/html/images/cancers-10-00517-g003.png?1570832959)
Cancers | Free Full-Text | In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer
РУССКОЕ ИЗДАНИЕ EDITOR Ted Gansler, MD, MBA, MPH American Cancer Society ASSOCIATE EDITORS Durado Brooks, MD, MPH
РУССКОЕ ИЗДАНИЕ EDITOR Ted Gansler, MD, MBA, MPH American Cancer Society ASSOCIATE EDITORS Durado Brooks, MD, MPH
![Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples - ScienceDirect Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0014480012000226-gr1.jpg)
Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples - ScienceDirect
РУССКОЕ ИЗДАНИЕ EDITOR Ted Gansler, MD, MBA, MPH American Cancer Society ASSOCIATE EDITORS Durado Brooks, MD, MPH
![Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples - ScienceDirect Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0014480012000226-gr2.jpg)
Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples - ScienceDirect
![Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples - ScienceDirect Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0014480012000226-gr3.jpg)
Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples - ScienceDirect
![Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples - ScienceDirect Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0014480012X00030-cov150h.gif)
Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples - ScienceDirect
![Cancers | Free Full-Text | In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer Cancers | Free Full-Text | In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer](https://www.mdpi.com/cancers/cancers-10-00517/article_deploy/html/images/cancers-10-00517-g006.png)
Cancers | Free Full-Text | In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer
![Cancers | Free Full-Text | In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer Cancers | Free Full-Text | In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer](https://www.mdpi.com/cancers/cancers-10-00517/article_deploy/html/images/cancers-10-00517-g010.png)
Cancers | Free Full-Text | In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer
![Prediction of blood-based biomarkers and subsequent design of bisulfite PCR-LDR-qPCR assay for breast cancer detection | BMC Cancer | Full Text Prediction of blood-based biomarkers and subsequent design of bisulfite PCR-LDR-qPCR assay for breast cancer detection | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-6574-4/MediaObjects/12885_2020_6574_Fig6_HTML.png)
Prediction of blood-based biomarkers and subsequent design of bisulfite PCR-LDR-qPCR assay for breast cancer detection | BMC Cancer | Full Text
![Frontiers | Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma Frontiers | Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma](https://www.frontiersin.org/files/Articles/456708/fonc-09-00556-HTML/image_m/fonc-09-00556-t001.jpg)
Frontiers | Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma
![Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples - ScienceDirect Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0014480012000226-gr4.jpg)
Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples - ScienceDirect
![The amplification profiles of CTLA-4 mRNA present in the examined samples. | Download Scientific Diagram The amplification profiles of CTLA-4 mRNA present in the examined samples. | Download Scientific Diagram](https://www.researchgate.net/publication/26312257/figure/fig3/AS:310023075975170@1450926669313/The-amplification-profiles-of-CTLA-4-mRNA-present-in-the-examined-samples.png)
The amplification profiles of CTLA-4 mRNA present in the examined samples. | Download Scientific Diagram
![Frontiers | Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma Frontiers | Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma](https://www.frontiersin.org/files/Articles/456708/fonc-09-00556-HTML/image_m/fonc-09-00556-g004.jpg)
Frontiers | Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma
![Prediction of blood-based biomarkers and subsequent design of bisulfite PCR-LDR-qPCR assay for breast cancer detection | BMC Cancer | Full Text Prediction of blood-based biomarkers and subsequent design of bisulfite PCR-LDR-qPCR assay for breast cancer detection | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-6574-4/MediaObjects/12885_2020_6574_Fig3_HTML.png)
Prediction of blood-based biomarkers and subsequent design of bisulfite PCR-LDR-qPCR assay for breast cancer detection | BMC Cancer | Full Text
![Cancers | Free Full-Text | In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer Cancers | Free Full-Text | In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer](https://www.mdpi.com/cancers/cancers-10-00517/article_deploy/html/images/cancers-10-00517-g002.png)
Cancers | Free Full-Text | In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer
![Cancers | Free Full-Text | In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer Cancers | Free Full-Text | In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer](https://www.mdpi.com/cancers/cancers-10-00517/article_deploy/html/images/cancers-10-00517-g007.png)
Cancers | Free Full-Text | In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer
![Cancers | Free Full-Text | In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer Cancers | Free Full-Text | In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer](https://pub.mdpi-res.com/cancers/cancers-10-00517/article_deploy/html/images/cancers-10-00517-g005.png?1570832959)
Cancers | Free Full-Text | In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer
![Frontiers | Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma Frontiers | Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma](https://www.frontiersin.org/files/Articles/456708/fonc-09-00556-HTML/image_m/fonc-09-00556-g002.jpg)
Frontiers | Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma
![Cancers | Free Full-Text | In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer Cancers | Free Full-Text | In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer](https://www.mdpi.com/cancers/cancers-10-00517/article_deploy/html/images/cancers-10-00517-g008.png)
Cancers | Free Full-Text | In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer
![Frontiers | Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma Frontiers | Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma](https://www.frontiersin.org/files/Articles/456708/fonc-09-00556-HTML/image_m/fonc-09-00556-g005.jpg)